Text size Joseph Prezioso / Getty Images Shares of Modern biotechnology fell 6.2% on Thursday afternoon after health news website Stat reported that the company was delaying the start of a Phase 3 trial of its experimental Covid-19 vaccine. The report, based on quotes from unidentified sources described as “investigators,” …
Read More »European stocks up on data, but US holidays keep stocks closed
European stocks were to snap a four-session winning streak on Friday, with bullish economic data overshadowed by lingering concerns about rising virus cases in the US. The Stoxx Europe 600 SXXP Index, -0.96% It fell 0.6% to 365.91, just after a gain of close to 2% on Thursday. For the …
Read More »Tesla founder Elon Musk shows short sellers on Twitter
Text size Elon Musk, CEO of Tesla and SpaceX, poses on the red carpet when he arrives at the 43rd “Goldenes Lenkrad” (golden flyer) on November 12, 2019 in Berlin. Photo by Tobias SCHWARZ / AFP AFP via Getty Images Tesla CEO Elon Musk is, frankly, a huge follower of …
Read More »Pfizer’s shares rise as the company reveals the timeline for the coronavirus vaccine.
Text size Daniel Acker / Bloomberg Shares of the large pharmaceutical company Pfizer continue to rise one day after the company revealed promising and detailed data on a trial of its experimental vaccine Covid-19. Analysts said the highly aggressive timeline the company outlined on Wednesday was exciting, but far from …
Read More »Dun & Bradstreet raises $ 1.7 billion as shares gain 15.2% on IPO debut
Text size Spencer Platt / Getty Images On their second trip to the equity markets, Dun & Bradstreet Holdings shares gained 15.2% in their trading debut on Wednesday. Dun & Bradstreet (ticker: DNB) shares traded up to 17% higher than their initial public offering price of $ 22. The shares …
Read More »